{
  "company": {
    "name": "ImmunoScape",
    "website": "https://immunoscope.com/",
    "record": "https://startuphistory.org/c/immunoscope.com"
  },
  "status": null,
  "history_since": null,
  "baseline": null,
  "live_captures": 0,
  "last_checked": null,
  "live_status": "js_only",
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Exogene",
      "record": "https://startuphistory.org/c/exogene.co.uk",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use deep learning and TCR screening to discover TCR-based immunotherapies for solid tumors"
    },
    {
      "name": "TScan Therapeutics",
      "record": "https://startuphistory.org/c/tscan.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both discover and develop TCR-based cell therapies for cancer including solid tumors"
    },
    {
      "name": "T-Therapeutics",
      "record": "https://startuphistory.org/c/t-therapeutics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both focus on next-generation TCR therapeutics for cancer indications"
    },
    {
      "name": "Immunai",
      "record": "https://startuphistory.org/c/immunai.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both apply ML to immune profiling to support discovery of novel immunotherapy targets and candidates"
    },
    {
      "name": "ImmunoMind",
      "record": "https://startuphistory.org/c/immunomind.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both offer AI-driven immunology platforms for designing personalized immune-targeting therapies"
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “ImmunoScape” company record, https://startuphistory.org/c/immunoscope.com"
}